BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1099534)

  • 1. [Letter: Acute myeloblastic leukemia: prevision of the efficiency by the combination of daunorubicin-cytosine-arabinoside].
    Zittoun R
    Nouv Presse Med; 1975 Jun; (23):1733. PubMed ID: 1099534
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of acute myeloblastic leukemia with cytosine arabinoside combined with daunorubicin or ifosfamide or thioguanine].
    Büchner T; Kamanabroo D; Hiddemann W; Urbanitz D
    Verh Dtsch Ges Inn Med; 1978; (84):145-8. PubMed ID: 283634
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 4. [Results in the treatment of acute granulocytic leukemias using a combination of daunorubicine-cytosine arabinoside-cyclophosphamide. Apropos of 35 cases].
    Bauters F; Plouvier B; Caulier MT; Mouton J; Goudemand M
    Lille Med; 1974 Mar; 19(3):226-31. PubMed ID: 4612276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute myeloblastic leukemia. 79 cases treated by cytosine-rubidomycin combination].
    Brun B; Rochant H; Gluckman E; Reyes F; Dreyfus B
    Nouv Presse Med; 1974 Feb; 3(6):291-4. PubMed ID: 4522835
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of 17 cases of non-lymphoblastic acute leukemia with a combination of daunorubicin, cytosine and arabinoside].
    Dini E; Barbui T; Cartei G; Chisesi T; Cazzavillan M; Battista R
    Minerva Med; 1975 Jul; 66(52):2619-2620. PubMed ID: 1057055
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequencing of cytosine arabinoside (NSC-63878) and daunorubicin (NSC-82151) in acute myelogenous leukemia.
    Omura GA
    Cancer Treat Rep; 1976 May; 60(5):629-31. PubMed ID: 1068745
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cytosine arabinoside alone and in association to other drugs in the therapy of acute myeloblastic leukemia].
    Tura S; Ricci P; Baccarani M; Lauria F; Santucci MA
    Haematologica; 1972; 57(7):359-70. PubMed ID: 4628583
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of acute myeloblastic leukemia by the combination of daunorubicin (or rubidazone) and cytosine arabinoside (apropos of 76 cases)].
    Bauters F; Jouet JP; Huart JJ; Jude B; Toussaint B; Goudemand M
    Lille Med; 1980 Dec; 25(10):559-68. PubMed ID: 6936592
    [No Abstract]   [Full Text] [Related]  

  • 10. Adriamycin-cytosine arabinoside therapy for adult acute myelocytic leukemia.
    Preisler HD; Bjornsson S; Henderson ES
    Cancer Treat Rep; 1977; 61(1):89-92. PubMed ID: 324625
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical use of cytosine arabinoside in infancy. I. Cytosine arabinoside in the treatment of acute leukosis].
    Masi M; Vivarelli F; Paolucci P; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(28):1539-50. PubMed ID: 1101022
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences in the treatment of acute myeloblastic leukemia and acute monocytic leukemia using cytosine arabinoside and 6-thioguanine].
    Essers U; Althof S; Ewers M
    Verh Dtsch Ges Inn Med; 1975; 81():1126-8. PubMed ID: 1065154
    [No Abstract]   [Full Text] [Related]  

  • 15. Androgen therapy during myeloblastic leukemia remission induced by two drug combinations.
    Pavlovsky S; Scaglione C; Eppinger-Helft M; Muriel FS; Macchi A; Garay G; Cavagnaro F; Birman V; Dupont J; Suarez A; Dragosky MO; Barros CA
    Medicina (B Aires); 1981; 41(1):11-8. PubMed ID: 7022104
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute promyelocytic leukemia: confirmation of the therapeutic value of the cytosine arabinoside-thioguanine combination].
    Monica C; Cucinotta D; Carapezzi C; Ceccato S
    G Clin Med; 1976; 57(5-6):192-9. PubMed ID: 1070455
    [No Abstract]   [Full Text] [Related]  

  • 17. [Letter: High remission rate in acute myeloid leukemia (AML) by adriamycin, vincristine and cytosine arabinoside combination. Importance of intensive hematological care].
    Mathé G; Pouillart P; De Vassal F; Delgado M; Schwarzenberg L; Misset JL; Hayat M
    Nouv Presse Med; 1976 Aug 28-Sep 4; 5(28):1758. PubMed ID: 1066659
    [No Abstract]   [Full Text] [Related]  

  • 18. [Trial treatment of acute myeloblastic leukemia with the cytosine arabinoside-cyclophosphamide association. (Apropos of 30 cases)].
    Bauters F; Lerche B; Samsoen J; Goudemand M
    Therapeutique; 1972 Apr; 48(4):303-8. PubMed ID: 4507025
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cytosine arabinoside on DNA synthesis as predictor for acute myelocytic leukemia (AML) patients' response to chemotherapy.
    Epstein J; Preisler H
    Eur J Cancer (1965); 1981 Jun; 17(6):623-8. PubMed ID: 6946929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.